Vanessa Carter has been awarded the Foundation for Innovative New Diagnostics (FIND) Voice for Diagnosis community prize for her advocacy work and shares her decade long battle with drug-resistant MRSA .
In this Q&A we chat with BioAmp Diagnostics, Longitude Prize team from Berkeley, to gain a better understanding of their new partnership with Illumina to validate their urinary tract infection (UTI) test.
The Longitude Prize team travelled to the states connecting our North American test developers with front-line healthcare professionals, ensuring the tests being developed are as impactful as possible.
"We have settled for merely adequate testing and levels of surveillance of AMR. This has to change if we are to survive AMR. We must decide that these levels of information are no longer enough," says Dr Christine Carson.
Following a competitive pitch, three start-ups have been awarded up to £100,000 each to further develop their rapid diagnostic tests with an aim to reduce avoidable use and better steer the use of antibiotics to win the Longitude Prize.
Our new patent report has pointed to a decline in the number of new point-of-care technologies being created to diagnose infectious disease and identify pathogens and antimicrobial resistance (AMR), amid a concerning lack of innovation and investment.
Using crafts as an educational tool, the Longitude Prize team have challenged the public to create an affordable and effective test to detect bacterial infections and tackle the growing levels of antibiotic resistance.